Results 41 to 50 of about 70,194 (263)

Cerebrovascular complications of COVID-19 on venovenous extracorporeal membrane oxygenation

open access: yes, 2023
: OBJECTIVES Evidence of cerebrovascular complications in COVID-19 requiring venovenous extracorporeal membrane oxygenation (ECMO) is limited. Our study aims to characterize the prevalence and risk factors of stroke secondary to COVID-19 in patients on ...
Mariani, Silvia   +14 more
core  

Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks

open access: yes, 2023
: Coronavirus Disease 2019 (COVID-19) vaccination has resulted in excellent protection against fatal disease, including in older adults. However, risk factors for post-vaccination fatal COVID-19 are largely unknown. We comprehensively studied three large
Kabamba, Benoit   +122 more
core  

ECMO for COVID-19 patients in Europe and Israel

open access: yes, 2021
: No abstract ...
Combes, Alain   +7 more
core  

The psychological burden of waiting for procedures and patient‐centred strategies that could support the mental health of wait‐listed patients and caregivers during the COVID‐19 pandemic: A scoping review

open access: yes, 2021
Background Waiting for procedures delayed by COVID‐19 may cause anxiety and related adverse consequences. Objective To synthesize research on the mental health impact of waiting and patient‐centred mitigation strategies that could be applied in the COVID‐
Robin Green   +19 more
core   +1 more source

Trombosis pada corona virus disease (COVID-19)

open access: yesJKS (Jurnal Kedokteran Syiah Kuala), 2020
Abstrak. Coronavirus Disease 2019 (COVID-19) telah menyebabkan masalah kesehatan di seluruh dunia dengan morbiditas dan mortalitas yang terus meningkat. Pada beberapa kasus COVID-19 diketahui terjadi manifestasi trombotik.
Agus Jati Sunggoro   +2 more
doaj   +1 more source

The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis

open access: yesBMC Infectious Diseases, 2023
Background With the emergence of coronavirus disease of 2019 (COVID-19), several blood biomarkers have been identified, including the endothelial biomarker syndecan-1, a surface proteoglycan.
Elina Ghondaghsaz   +5 more
doaj   +1 more source

Well-posedness and qualitative analysis of a SEIR model with spatial diffusion for COVID-19 spreading

open access: yesBiomath, 2023
In this paper, we study the well-posedness and the qualitative behavior of equilibria of a SEIR epidemic models with spatial diffusion for the spreading of COVID-19.
José Paulo Carvalho dos Santos   +4 more
doaj   +1 more source

GG COVID-19 Omicron/Delta PCR study Proposal

open access: yes, 2022
Most U.S. doctors have no way to determine which variant of the coronavirus a patient is carrying, a distinction that could mean the difference between life and death.
Jung Joo Moon
core   +1 more source

Mental, cognitive and physical outcomes after intensive care unit treatment during the COVID-19 pandemic: a comparison between COVID-19 and non-COVID-19 patients

open access: yesScientific Reports, 2023
To compare mental, cognitive and physical outcomes between COVID-19 and non-COVID-19 patients, 3–6 months after Intensive Care Unit (ICU) treatment during the COVID-19 pandemic and to compare mental outcomes between relatives of these patients.
Fedor van Houwelingen   +7 more
doaj   +1 more source

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy